On the first day of the JPM Healthcase Conference, AbbVie announced that it would acquire the global rights outside China to ...

Eli Lilly (LLY) heads into 2026 with GLP-1 pricing and competition risks; oral GLP-1 race heats up and downside looms.

Speaking at the J.P. Morgan conference, CEO David Ricks said he anticipates a “rapid review” for orforglipron that's ...

“The dynamics of the policy changes that have occurred in the last year-plus since the Trump administration are certainly ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...

Jan 13 () - Global drugmakers are ramping up U. manufacturing and stockpiling inventory as the Trump administration considers ...

NVIDIA and Eli Lilly are investing US$1bn to develop an AI lab, pioneering robotics and physical AI to accelerate medicine ...

ASX 200 futures are up 27pts (+0.30%) as of 8:30 am AEDT. Here's what you need to know before the market opens.

Nvidia Corp. plans to invest US$1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the ...